Insider · CIK 0001361712

Stampacchia Otello

CIK 0001361712 Name as filed on the most recent filing

Filed as Stampacchia Otello (91)

318 transaction lines · from 91 filings · filed 2007-06-26 to 2025-07-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

53 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-07-25 P, Open-market purchase ImageneBio, Inc.IMA 7,999,924, acquired Open Form 4 filing 0001415889-25-020598
2023-11-07 P, Open-market purchase Lexeo Therapeutics, Inc.LXEO 4,999,995, acquired Open Form 4 filing 0001209191-23-054913
2022-03-16 S, Open-market sale Replimune Group, Inc.REPL 2 lines 698,253, disposed Open Form 4 filing 0000899243-22-011332
2022-03-15 S, Open-market sale Replimune Group, Inc.REPL 703,800, disposed Open Form 4 filing 0000899243-22-011332
2022-03-14 S, Open-market sale Replimune Group, Inc.REPL 254,430, disposed Open Form 4 filing 0000899243-22-011332
2021-11-22 S, Open-market sale Replimune Group, Inc.REPL 352,621, disposed Open Form 4 filing 0000899243-21-045798
2021-11-19 S, Open-market sale Replimune Group, Inc.REPL 2 lines 1,218,058, disposed Open Form 4 filing 0000899243-21-045798
2021-11-18 S, Open-market sale Replimune Group, Inc.REPL 81,774, disposed Open Form 4 filing 0000899243-21-045302
2021-11-18 S, Open-market sale Replimune Group, Inc.REPL 81,774, disposed Open Form 4 filing 0000899243-21-045301
2021-11-16 S, Open-market sale Replimune Group, Inc.REPL 5,126, disposed Open Form 4 filing 0000899243-21-045302
2021-11-16 S, Open-market sale Replimune Group, Inc.REPL 5,126, disposed Open Form 4 filing 0000899243-21-045301
2021-11-15 S, Open-market sale Replimune Group, Inc.REPL 26,322, disposed Open Form 4 filing 0000899243-21-044774
2021-11-12 S, Open-market sale Replimune Group, Inc.REPL 782,090, disposed Open Form 4 filing 0000899243-21-044774
2021-11-11 S, Open-market sale Replimune Group, Inc.REPL 614,357, disposed Open Form 4 filing 0000899243-21-044322
2021-11-10 S, Open-market sale Replimune Group, Inc.REPL 369, disposed Open Form 4 filing 0000899243-21-044322
2021-11-09 S, Open-market sale Replimune Group, Inc.REPL 254,223, disposed Open Form 4 filing 0000899243-21-043855
2021-11-08 S, Open-market sale Replimune Group, Inc.REPL 127,984, disposed Open Form 4 filing 0000899243-21-043855
2021-11-05 S, Open-market sale Replimune Group, Inc.REPL 193,965, disposed Open Form 4 filing 0000899243-21-043456
2021-11-04 S, Open-market sale Replimune Group, Inc.REPL 847,056, disposed Open Form 4 filing 0000899243-21-043456
2021-10-12 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 3,000,000, acquired Open Form 4 filing 0000899243-21-040245
2021-09-23 S, Open-market sale Replimune Group, Inc.REPL 408,702, disposed Open Form 4 filing 0000899243-21-037893
2021-09-17 S, Open-market sale Replimune Group, Inc.REPL 2 lines 3,118,779, disposed Open Form 4 filing 0000899243-21-036546
2021-09-16 S, Open-market sale Replimune Group, Inc.REPL 180,229, disposed Open Form 4 filing 0000899243-21-036546
2021-04-30 S, Open-market sale Morphic Holding, Inc.MORF 3 lines 523,075, disposed Open Form 4 filing 0000899243-21-017711
2021-04-29 S, Open-market sale Morphic Holding, Inc.MORF 3 lines 414,587, disposed Open Form 4 filing 0000899243-21-017711
2021-04-28 S, Open-market sale Morphic Holding, Inc.MORF 2 lines 187,536, disposed Open Form 4 filing 0000899243-21-017342
2021-04-27 S, Open-market sale Morphic Holding, Inc.MORF 3 lines 405,718, disposed Open Form 4 filing 0000899243-21-017342
2021-04-26 S, Open-market sale Morphic Holding, Inc.MORF 3 lines 290,993, disposed Open Form 4 filing 0000899243-21-017064
2021-04-23 S, Open-market sale Morphic Holding, Inc.MORF 4 lines 482,775, disposed Open Form 4 filing 0000899243-21-017064
2021-04-22 S, Open-market sale Morphic Holding, Inc.MORF 5 lines 704,075, disposed Open Form 4 filing 0000899243-21-016863
2021-04-21 S, Open-market sale Morphic Holding, Inc.MORF 202,502, disposed Open Form 4 filing 0000899243-21-016863

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 49
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Stampacchia Otello, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001361712

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.